Walleye Trading LLC Beam Therapeutics Inc. Call Options Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $307,806 - $535,224	17,400 Added 130.83%	30,700 $835,000
Q3 2023 Nov 14, 2023	SELL	$23.01 - $32.46 $1.03 Million - $1.46 Million	-44,900 Reduced 77.15%	13,300 $319,000
Q2 2023 Aug 14, 2023	BUY	$29.32 - $35.99 $867,872 - $1.07 Million	29,600 Added 103.5%	58,200 $1.86 Million
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $138,690 - $224,434	4,600 Added 19.17%	28,600 $875,000
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $1.55 Million - $2.18 Million	-42,300 Reduced 63.8%	24,000 $938,000
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $2.24 Million - $3.96 Million	56,300 Added 563.0%	66,300 $3.16 Million
Q2 2022 Aug 08, 2022	BUY	$29.86 - $62.36 $170,202 - $355,452	5,700 Added 132.56%	10,000 $387,000
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $231,039 - $353,288	4,300 New	4,300 $246,000

240

76.3M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.93B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.